ArticleInternational journal of molecular sciences2022

DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma.

Anne V Yagolovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.